Although a role for GCN2 in amino acid metabolism and the anti-tumor efficacy of GCN2 inhibition has been demonstrated, whether GCN2 inhibition is a potential therapeutic strategy to target tumor-associated T cells needs further evaluation. This evidence concerns the gene EIF2AK4 and neoplasm.